Dr Reddy's Laboratories Q2 profit falls 36% amid lower lenalidomide sales

Statements (10 of 11)

1. ▲ Bullish

   Dr. Reddy's Laboratories reported a profit of ₹1,000 crore in the second quarter.

   cnbctv18.comOct 26, 2026 15:54 UTCHigh importance
2. ▼ Bearish

   Dr. Reddy's Labs posted a 36% drop in second-quarter profit.

   economictimes.indiatimes.comOct 24, 2026 03:53 UTC
3. ▼ Bearish

   Dr. Reddy's Q2 net income dropped 32% to ₹913 crore

   thehindu.comOct 23, 2026 16:13 UTCHigh importance
4. ▼ Bearish

   Dr. Reddy's Q2 revenue fell 1.8% year over year to ₹8,697.8 crore

   thehindu.comOct 23, 2026 16:13 UTCHigh importance
5. ▼ Bearish

   Dr Reddy's Q2 profit fell 36% due to lower lenalidomide sales in North America

   business-standard.comOct 23, 2026 14:25 UTCHigh importance
6. ▼ Bearish

   Dr Reddy's Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27

   economictimes.indiatimes.comOct 23, 2026 13:32 UTCHigh importance
7. ▼ Bearish

   Dr Reddy's Laboratories revenue slipped 1.5% in Q2 FY27

   economictimes.indiatimes.comOct 23, 2026 13:32 UTC
8. ▼ Bearish

   Dr Reddy's Laboratories reported a 1.5% year-over-year decline in revenue to ₹8,671 crore in Q2 FY27.

   cnbctv18.comOct 23, 2026 13:06 UTCHigh importance
9. ▼ Bearish

   Dr Reddy's Laboratories reported a 36% year-over-year decline in net profit to ₹913.4 crore in Q2 FY27.

   cnbctv18.comOct 23, 2026 13:06 UTCHigh importance
10. ▼ Bearish

    Dr. Reddy's Laboratories reported a profit drop in the second quarter of fiscal 2027

    nasdaq.comOct 23, 2026 13:01 UTC

1 more statement on this development this week. The API returns all of them: GET /v2/statements?topic_id=7c3de6a1-9f0e-4c0a-8314-0c3f47090b4c Get a free API key ↗